Vident Advisory, LLC Grifols Sa Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Grifols Sa stock. As of the latest transaction made, Vident Advisory, LLC holds 13,144 shares of GRFS stock, worth $117,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,144
Previous 22,039
40.36%
Holding current value
$117,244
Previous $147 Million
43.71%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GRFS
# of Institutions
147Shares Held
151MCall Options Held
2.38MPut Options Held
662K-
Capital World Investors Los Angeles, CA20.9MShares$186 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA18.6MShares$166 Million1.52% of portfolio
-
Permian Investment Partners, LP New York, NY14.1MShares$126 Million11.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny13.9MShares$124 Million0.04% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.3MShares$110 Million2.9% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $6.06B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...